Impurity Reference Standards Across Therapeutic Areas: What Analytical Labs Need to Know
Impurity profiling looks different depending on which drug class you're testing. A diabetes drug, a statin, and an anticoagulant each carry their own set of process-related impurities, degradation products, and pharmacopeial (USP/EP) related compounds. Having the right, well-characterized reference standard for each is what actually makes a validated analytical method possible. Here's a practical look at three real examples spanning three major therapeutic categories — and why sourcing the correct reference standard matters more than it might seem. Quick Reference: The Three Impurities at a Glance Therapeutic Area Drug Impurity CAS No. Diabetes (SGLT2 inhibitor) Dapagliflozin Hydroxy Dapagliflozin (USP) 1204222-85-4 Cardiovascular (Statin) Pravastatin EP Impurity A (6′-Epipravastatin) 81176-41-2 Anticoagulant Dabigatran Etexilate Despyridyl Ethyl Ester 1408238-36-7 Diabetes: Dapagliflozin and Its Impurity Profile Dapagliflozin is an SGLT2 inhibitor widely used in ...